This pilot trial is enrolling 15 individuals with chronic spinal cord injuries to test the safety and feasibility of two versions of the TWIICE Rise, a lower-limb exoskeleton designed to enhance walking function. An exoskeleton is an externally worn powered robotic device to assist movement. If included, participants will undergo a training program with the exoskeleton. In the first phase, 5 participants will undergo 6 sessions for up to 6 weeks using TWIICE Rise 0 in a clinical setting. In the second phase, 10 participants will undergo 24 sessions for up to 20 weeks using an improved device, TWIICE Rise 1, in different settings (clinic, home, and community environment). Final assessment of safety and feasibility will be done after up to 26 weeks.
Traumatic
Non-traumatic
Type
Details
- Participants will undergo a training programme with one of two versions of the TWIICE Rise. - The TWIICE Rise is a lower-limb overground robotic exoskeleton designed to enhance walking function. - Phase 1: 5 participants will undergo a total of 6 sessions for up to 6 weeks in a clinic. - Phase 2: 10 participants will undergo a total of 24 sessions for up to20 weeks in different settings (clinic, home, and community environment). - Final assessment of safety and feasibility of the TWIICE Rise will be done after up to 26 weeks.
Main benefits
General health
Additional benefits
Pain
Skin health
Standing/walking/mobility
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more